SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-059337
Filing Date
2023-12-20
Accepted
2023-12-20 16:22:01
Documents
1
Period of Report
2023-11-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 11283
  Complete submission text file 0001209191-23-059337.txt   13881
Mailing Address 1455 NW LEARY WAY SUITE 400 SEATTLE WA 98107
Business Address 1455 NW LEARY WAY SUITE 400 SEATTLE WA 98107 206-227-3078
22NW Fund, LP (Reporting) CIK: 0001640809 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-40388 | Film No.: 231501543

Mailing Address 590 1ST AVE S, UNIT C1 SEATTLE WA 98104
Business Address 590 1ST AVE S, UNIT C1 SEATTLE WA 98104 206-437-9174
22NW, LP (Reporting) CIK: 0001694297 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-40388 | Film No.: 231501544

Mailing Address 1455 NW LEARY WAY, SUITE 400 SEATTLE WA 98107
Business Address
English Aron R. (Reporting) CIK: 0001770436 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40388 | Film No.: 231501545

Mailing Address JFL CAPITAL MANAGEMENT 1017 RR 620 S, SUITE 107 LAKEWAY TX 78734
Business Address JFL CAPITAL MANAGEMENT 1017 RR 620 S, SUITE 107 LAKEWAY TX 78734 737 203 5270
Anebulo Pharmaceuticals, Inc. (Issuer) CIK: 0001815974 (see all company filings)

IRS No.: 851170950 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)